SIRT1 activation by the use of transgenic mice or viral vectors demonstrated protection in different neurodegenerative diseases such as ALS, AD, and HD [207,208,209] and also after nerve injury [55]. This evidence concerns the gene SIRT1 and Alzheimer disease.